{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:11:02Z","timestamp":1790223062445,"version":"4.1.0"},"reference-count":68,"publisher":"National Academy of Sciences","issue":"18","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM147696"],"award-info":[{"award-number":["GM147696"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024870","name":"NWO | Exacte en Natuurwetenschappen","doi-asserted-by":"publisher","award":["OCENW.M20.200"],"award-info":[{"award-number":["OCENW.M20.200"]}],"id":[{"id":"10.13039\/501100024870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015834","name":"Ono Pharma Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100015834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:p>\n                    Noonan syndrome (NS) is the most common RASopathy, a developmental disorder that derives from dysregulation of the mitogen-activated protein kinase (MAPK) pathway. NS results from modestly activating mutations in proteins throughout the pathway. Trametinib, a MEK inhibitor, has shown promising results for certain NS complications, but NS-specific therapeutic options are lacking. CRAF activity, which is governed by the adaptor protein 14-3-3, represents a key NS regulatory node that has not been exploited. When phosphorylated (p) at CRAF S259, the 14-3-3\/CRAF-pS259 complex adopts an inactive conformation in which CRAF does not fully bind to RAS or to other RAFs. NS mutations in CRAF occur at residues surrounding S259 (CRAF\n                    <jats:sup>NS<\/jats:sup>\n                    ). Here, we quantify how these mutations impair 14-3-3\/CRAF, both through decreased phosphorylation (64 to 97%) and decreased binding affinity to 14-3-3 (three- to &gt;100-fold decrease). We also explore the potential of restoring homeostasis in NS using molecular glues (MGs) to enhance the 14-3-3\/CRAF inhibitory complex. We report that MGs protect phosphorylation of CRAF\n                    <jats:sup>WT<\/jats:sup>\n                    -pS259 in CRAF-effector NS mutant backgrounds. They also stabilize 14-3-3\/CRAF\n                    <jats:sup>NS<\/jats:sup>\n                    interactions and increase the levels of S259 phosphorylation up to 2.8-fold, leading to decreased association of CRAF with NRAS and decreased formation of the active CRAF kinase dimers. Ultimately, inhibition of CRAF activation leads to decreased phosphorylation of the downstream target ERK, similarly to trametinib, in three different NS variants (activation of the phosphatase SHOC2, CRAF\n                    <jats:sup>S257L<\/jats:sup>\n                    , and CRAF\n                    <jats:sup>V263A<\/jats:sup>\n                    ). These results reveal a potential therapeutic strategy for NS and related RASopathies. They also demonstrate the scope and limitations of stabilizing mutation-weakened complexes with molecular glues.\n                  <\/jats:p>","DOI":"10.1073\/pnas.2602101123","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:59:57Z","timestamp":1777399197000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":3,"title":["Restoring the 14-3-3\/CRAF regulatory interaction in Noonan syndrome using molecular glues"],"prefix":"10.1073","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9893-5565","authenticated-orcid":false,"given":"Johanna M.","family":"Virta","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California","place":["San Francisco"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly R.","family":"Vickery","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California","place":["San Francisco"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markella","family":"Konstantinidou","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California","place":["San Francisco"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mckenna C.","family":"Crawford","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California","place":["San Francisco"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes A. M.","family":"Pennings","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology","place":["Eindhoven, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7315-0315","authenticated-orcid":false,"given":"Christian","family":"Ottmann","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology","place":["Eindhoven, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5675-511X","authenticated-orcid":false,"given":"Luc","family":"Brunsveld","sequence":"additional","affiliation":[{"name":"Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology","place":["Eindhoven, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-6770","authenticated-orcid":false,"given":"Michelle R.","family":"Arkin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California","place":["San Francisco"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2019.02.012"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2021.11.012"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.8b11658"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.2c01449"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049967u"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.adx3595"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.5c00441"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2024.04.002"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.10.022"},{"key":"e_1_3_4_10_2","first-page":"3438","article-title":"Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation","volume":"82","author":"Garc\u00eda-Alonso S.","year":"2022","unstructured":"S. Garc\u00eda-Alonso , Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation. Biochemistry 82, 3438\u20133452.e8 (2022).","journal-title":"Biochemistry"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8085158"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.07.046"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.07.092"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/27938"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2011.09.001"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228824"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0348-3"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20091834"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20200084"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21187"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng2078"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2024.168483"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1660-y"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63227-2"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28084-3"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720352115"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902658116"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2021.06.004"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049107"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1134\/S1022795420050117"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.09.002"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61023-X"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-023-05263-y"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01636-09"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c05161"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202008585"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57241-7"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.04.005"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c03035"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5c12622"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61176-4"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmch.2021.01.002"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/340847"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21492"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.051276"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2297-8"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.425"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.116"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36098"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05013-8"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay0543"},{"key":"e_1_3_4_52_2","doi-asserted-by":"crossref","unstructured":"D. A. Ritt An in vitro BRAF activation assay elucidates molecular mechanisms driving disassembly of the autoinhibited BRAF state. bioRxiv [Preprint] (2025) https:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.08.19.671159 (Accessed 19 September 2025).","DOI":"10.1073\/pnas.2508169122"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0723-9"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010141"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911407323"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2007.05.001"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2008.10.003"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09763-9"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202308004"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.slasd.2024.100165"},{"key":"e_1_3_4_61_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3 CRAF R256S NS mutant phosphopeptide (pS259) and compound 78 (1124378). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2I. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2i\/pdb"},{"key":"e_1_3_4_62_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF S257L NS mutant phosphopeptide (pS259) and compound 78 (1084378). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2J. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2j\/pdb"},{"key":"e_1_3_4_63_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF V263A NS mutant phosphopeptide (pS259) and compound 78 (1124378). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2K. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2k\/pdb"},{"key":"e_1_3_4_64_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF R256S NS mutant phosphopeptide (pS259) and compound 23 (1083848). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2L. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2l\/pdb"},{"key":"e_1_3_4_65_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF S257L NS mutant phosphopeptide (pS259) and compound 23 (1083848). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2M. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2m\/pdb"},{"key":"e_1_3_4_66_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF V263A NS mutant phosphopeptide (pS259) and compound 23 (1083848). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2N. Deposited 30 July 2025.","DOI":"10.2210\/pdb9s2n\/pdb"},{"key":"e_1_3_4_67_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF R256S NS mutant phosphopeptide (pS259) and compound 22 (1083853). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2O. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2o\/pdb"},{"key":"e_1_3_4_68_2","doi-asserted-by":"crossref","unstructured":"J. M. Virta . Ternary structure of 14-3-3s CRAF V263A NS mutant phosphopeptide (pS259) and compound 22 (1083853). Protein Data Bank. https:\/\/www.rcsb.org\/structure\/9S2P. Deposited 21 July 2025.","DOI":"10.2210\/pdb9s2p\/pdb"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2602101123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:00:35Z","timestamp":1777399235000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/10.1073\/pnas.2602101123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":68,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,5,5]]}},"alternative-id":["10.1073\/pnas.2602101123"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2602101123","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"2026-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2602101123"}}